DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |
| Virtus ETF Advisers LLC | 18,313 | $43,219 | 0.03% |
| Baker Brothers Advisors | 1,500,000 | $3,540,000 | 0.02% |
| XTX Topco Ltd | 38,472 | $90,794 | 0.02% |
| PDT Partners, LLC | 33,682 | $79,490 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 43,581 | $103 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 33,400 | $78,824 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,500 | $189,980 | 0.01% |
| Candriam S.C.A. | 225,000 | $531,000 | 0.00% |
| Jump Financial, LLC | 46,700 | $110,212 | 0.00% |
| ALGERT GLOBAL LLC | 35,620 | $84 | 0.00% |
External links
This page lists DESIGN THERAPEUTICS INC's shareholders in Q3 2023. To view DESIGN THERAPEUTICS INC's shareholder history, click here.